Allergan plc (AGN)


NYSE - NYSE Real Time Price. Currency in USD
230.80-6.99 (-2.94%)
At close: 4:04 PM EDT
People also watch:
BIIBCELGVRXGILDREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open237.05
Prev Close237.79
Bid229.50 x 100
Ask232.50 x 1500
Day's Range229.61 - 238.13
52wk Range195.50 - 322.68
1y Target EstN/A
Market Cap91.39B
P/E Ratio (ttm)21.97
Beta1.17
Volume4,324,585
Avg Vol (3m)2,998,381
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire9 hours ago

    Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals

    DUBLIN, Sept. 29, 2016 /PRNewswire/ -- Allergan plc (AGN), today issued the following statement regarding ongoing litigation on patents related to NAMENDA XR® (memantine hydrochloride) extended release capsules following announcement of FDA final ANDA approval by Lupin. One of the licensed patent families covering Namenda XR has been held invalid by the Federal District Court for the District of Delaware.  That decision is under appeal to the U.S. Court of Appeals for the Federal Circuit. The Company will defend the validity of these patents on appeal and believes that its arguments on appeal are substantial and meritorious.

  • TheStreet.com11 hours ago

    Are Hedge Funds Technically Wrong?

    Charts show 'hedge hogs' shouldn't dump AAPL and some other big-caps.

  • TheStreet.comyesterday

    5 Stocks Hedge Funds Hate -- Should You Too?

    The stocks that professional investors hate the most might just be telling you something this fall…